This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio X Cell
product type :
antibody
product name :
InVivoMAb anti-mouse CD80 (B7-1)
catalog :
BE0365-5MG
quantity :
5 mg
price :
390.00 USD
clonality :
monoclonal
host :
rat
conjugate :
nonconjugated
clone name :
RM80
The same clone is also sold as:
The same clone is also sold as:
- OriGene: AM05570FC-T, AM05570PU-N, AM05570FC-N, AM05570RP-N, AM05570PU-T, AM05570PU-L
- Bio-Rad: MCA2462SBUV445, MCA2462A488, MCA2462SBUV575, MCA2462A647, MCA2462SBV515, MCA2462SBV440, MCA2462GA, MCA2462SBV475, MCA2462SBUV795, MCA2462PE, MCA2462A647T, MCA2462SBUV400, MCA2462SBUV665, MCA2462SBV760, MCA2462SBV790, MCA2462SBV570, MCA2462SBV710, MCA2462SBB700, MCA2462F, MCA2462SBUV605, MCA2462SBUV510, MCA2462SBUV740, MCA2462SBV610, MCA2462SBV670
reactivity :
mouse
application :
flow cytometry
citations: 2
| Reference |
|---|
Saegusa K, Ishimaru N, Yanagi K, Haneji N, Nishino M, Azuma M, et al. Treatment with anti-CD86 costimulatory molecule prevents the autoimmune lesions in murine Sjögren's syndrome (SS) through up-regulated Th2 response. Clin Exp Immunol. 2000;119:354-60 pubmed
|
product information
Catalog Number :
BE0365-5MG
Product Name :
InVivoMAb anti-mouse CD80 (B7-1)
Host :
Rat
Clonality :
Monoclonal
Label/Conjugation :
No
Antigen Modification :
No
Category :
Antibody
Size :
5 mg
Regular Price :
$600.00
Academic Price :
390.00 USD
Clone Name :
RM80
Isotype :
RM80
Immunogen :
Mouse BCL1 cells expressing CD80
Reactivity :
Mouse
Concentration/Amount :
Lot specific,typically between 4-11 mg/ml
Reported Applications :
in vivo CD80 blockade, in vitro CD80 blockade, Flow cytometry
Recommended Storage Conditions :
The antibody solution should be stored at the stock concentration at 4°C. Do not freeze.
company information
Bio X Cell
10 Technology Dr., Suite 2B
Lebanon, NH 03784-1671
Lebanon, NH 03784-1671
customerservice@bxcell.com
http://bxcell.com1-866-787-3444
headquarters: USA
questions and comments
